Acute Fatty Liver of Pregnancy and Mimicking Alleviating Factors: A True Diagnostic Challenge in Resource-Limited Settings. Case Report and Literature Review

Main Article Content

Valenzuela Pacheco Libertad
Gómez Pineda María Paula
Nuñez Ramírez María Eugenia

Abstract

Acute fatty liver of pregnancy (AFLP) is a rare but potentially life-threatening obstetric complication, with an estimated incidence ranging from 1 in 7,000 to 20,000 pregnancies. Despite advances in diagnosis and treatment, its high maternal–fetal morbidity and mortality rates make it a true clinical challenge, particularly in hospitals with limited resources. This paper presents a complex clinical case with multiple variants simulating other pathologies, along with a comprehensive literature review that integrates international, regional, and national evidence. The analysis focuses on the diagnostic difficulty posed by differential entities such as HELLP syndrome, intrahepatic cholestasis, viral hepatitis, autoimmune diseases, dyslipidemias, and abdominal tumors. In addition, key clinical and laboratory tools—particularly the Swansea criteria—are highlighted as essential for standardizing diagnosis when specialized tests are unavailable. Based on the literature synthesis and the case analysis, a diagnostic algorithm and a table of pragmatic strategies tailored for low-resource settings are proposed, aiming to reduce delays and improve maternal–fetal outcomes.

Article Details

How to Cite
Libertad, Valenzuela Pacheco, Gómez Pineda María Paula, and Nuñez Ramírez María Eugenia. 2026. “Acute Fatty Liver of Pregnancy and Mimicking Alleviating Factors: A True Diagnostic Challenge in Resource-Limited Settings. Case Report and Literature Review”. International Journal of Medical Science and Clinical Research Studies 6 (01):84-95. https://doi.org/10.47191/ijmscrs/v6-i1-11.
Section
Articles

References

I. Acevedo A, Soutelo J, Lutfi R. Hyperlipidemia in pregnancy and its obstetric and metabolic complications. Rev Argent Endocrinol Metab. 2024;61(2):115–124.

II. Aguilar-Cordero MJ, Sánchez-García JC, Guisado-Barrilao R, Mur-Villar N, García-García I. Lipid metabolism disorders during pregnancy: Systematic review. J Negat No Posit Results. 2021;6(10):956–968. doi:10.47750/jnnpr.2021.610

III. Arriaga E, Pérez L, Gómez C. Intrahepatic cholestasis of pregnancy: update and management in resource-limited settings. Rev Mex Ginecol Obstet. 2023;91(3):147–156.

IV. Bourque M, Mahone K. Genetic basis of acute fatty liver of pregnancy: The role of LCHAD deficiency. J Hepatol Metab. 2025;74(1):45–53. doi:10.1016/j.jhepmet.2025.01.005

V. Ferrero S, Ragni N, Venturini P. Acute fatty liver of pregnancy: Clinical features and differential diagnosis. Int J Gynecol Obstet. 2020;149(2):143–150. doi:10.1002/ijgo.13105

VI. Joueidi Y, Robert-Gnansia E, Le Guenno G. Acute fatty liver of pregnancy: Clinical update and management. Liver Int 2020;40(8):1866–1875. doi:10.1111/liv.14512

VII. Lim JH, Kim MJ, Han SH. Clinical characteristics and management of acute fatty liver of pregnancy. Obstet Med. 2021;14(3):123–131. doi:10.1177/1753495X20984655

VIII. McLaughlin K, James MT, Hemmelgarn BR. Pregnancy-related acute kidney injury: A global perspective. Kidney Int Rep 2022;7(5):1012–1024. doi:10.1016/j.ekir.2022.02.015

IX. Meng J, Wang S, Zhang X. Advances in the diagnosis and treatment of acute fatty liver of pregnancy. Front Med. 2021;8:689015. doi:10.3389/fmed.2021.689015

X. Navarrete-López M, Pacheco-Domínguez M, Ramírez-Ramírez C. Acute fatty liver of pregnancy: a case series in a tertiary care hospital in Mexico. Rev Ginecol Obstet Mex. 2021;89(4):251–258.

doi:10.24245/gineobs.v89i4.2219

XI. Rahman TM, Wendon J. Severe hepatic dysfunction in pregnancy. QJM. 2002;95(6):343–357.

doi:10.1093/qjmed/95.6.343

XII. Santana DS, Surita FG, Cecatti JG. Acute fatty liver of pregnancy: Report of cases and review. Rev Bras Ginecol Obstet. 2005;27(10):605–612. doi:10.1590/S0100-72032005001000007

XIII. Scime NV, Walker M, Wen SW. Pregnancy complications and subsequent autoimmune disease risk: A population-based cohort study. CMAJ. 2024;196(5):E127–E135. doi:10.1503/cmaj.230456

XIV. Stander H, Cadden JA. Acute idiopathic hepatic disease of pregnancy. Am J Obstet Gynecol. 1934;28(1):110–120. doi:10.1016/S0002-9378(34)90262-4

XV. Tan J, Hou Y. Differential diagnosis and management of acute fatty liver of pregnancy. World J Clin Cases. 2021;9(34):10549–10561. doi:10.12998/wjcc.v9.i34.10549

XVI. Trakarnvanich T, Li S, Thongprayoon C. Pregnancy-related acute kidney injury: A systematic review and meta-analysis. BMC Nephrol. 2022;23(1):211. doi:10.1186/s12882-022-02832-0

XVII. Yemde M, Singh R, Gupta R. Acute fatty liver of pregnancy: Diagnostic challenges and outcomes in low-resource settings. J Matern Fetal Neonatal Med 2023;36(2):215–223. doi:10.1080/14767058.2021.1953212

XVIII. World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194.

XIX. Mexico. Congress of the Union. General Health Law. Official Gazette of the Federation, February 7, 1984. Last amendment in force.